Immunization with a hemagglutinin-derived synthetic peptide formulated with a CpG-DNA-liposome complex induced protection against lethal influenza virus infection in mice.
Whole-virus vaccines, including inactivated or live-attenuated influenza vaccines, have been conventionally developed and supported as a prophylaxis. These currently available virus-based influenza vaccines are widely used in the clinic, but the vaccine production takes a long time and a huge number...
Main Authors: | Jae Won Rhee, Dongbum Kim, Byung Kwon Park, Sanghoon Kwon, Sunhee Cho, Ilseob Lee, Man-Seong Park, Jae-Nam Seo, Yong-Sun Kim, Hong Seok Choi, Younghee Lee, Hyung-Joo Kwon |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3492448?pdf=render |
Similar Items
-
Production of antibodies with peptide-CpG-DNA-liposome complex without carriers
by: Kim Doo-Sik, et al.
Published: (2011-05-01) -
Prevention and therapy of hepatocellular carcinoma by vaccination with TM4SF5 epitope-CpG-DNA-liposome complex without carriers.
by: Sanghoon Kwon, et al.
Published: (2012-01-01) -
CD83 expression induced by CpG-DNA stimulation in a macrophage cell line RAW 264.7
by: Min Chul Park, et al.
Published: (2013-09-01) -
Anti-Bacterial Effect of CpG-DNA Involves Enhancement of the Complement Systems
by: Te Ha Kim, et al.
Published: (2019-07-01) -
ASB9 interacts with ubiquitous mitochondrial creatine kinase and inhibits mitochondrial function
by: Kim Doo-Sik, et al.
Published: (2010-03-01)